Cerecin's Series C Round

Cerecin raised a round of funding on November 24, 2008.

Cerecin, fka Accera, is a biopharmaceutical company with a drug for Alzheimer's in late stage clinical testing. Accera's pipeline consists of therapeutic drugs and medical foods for neurodegenerative …

Articles about Cerecin's Series C Round: